BRCA2 and breast cancer: Three mutations (185delAG and 5382insC in BRCA1 and 6174delT in BRCA2) have been defined as founder mutations [46], and three founder mutations, BRCA1 5382insC, C61G and 4153delA, are common in Polish familial BC patients [47].